Feed Hedge Funds Ban Employees from Taking Ozempic August 28, 2026 0 Min Read Share 0 Min Read SHARE Several hedge funds are reportedly prohibiting employees from using Ozempic, a popular diabetes and weight-loss medication, citing concerns about potential side effects impacting job performance. Share This Article Facebook Twitter Copy Link Leave a comment Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Hackers Offer Hospital Patients $2,500 After Data BreachHackers who breached a hospital's systems have apologized, offering affected patients up… Hong Kong Launches 24/7 Tokenized Settlements and Stablecoin TrialsHong Kong's financial authorities are enabling round-the-clock tokenized settlement systems and planning… Ethereum Whale Buys $63 Million in ETH, Suggests Market BottomA large Ethereum holder, or 'whale,' purchased $63 million worth of ETH.… Bitcoin Bull Market Withstood $6.3 Billion Hack, Showing ResilienceDespite a massive $6.3 billion hack, Bitcoin's bull market demonstrated resilience, with… Sam Altman’s RAM Plan for AI Data Centers Faces Crypto OppositionOpenAI CEO Sam Altman proposed using PC RAM for AI data centers,… BTCPay Server Warns of Shutdown Due to Hot Wallet AttacksBTCPay Server has issued an emergency warning advising users to shut down…
